Skip to main content

Table 2 weight and white blood cells changes of tumor-burdened mouse before and after treatment

From: Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol

Group Body weight (\( \overline{\mathrm{x}} \)±S g) Peripheral blood (WBC, \( \overline{\mathrm{x}} \) ±S,106)
IBW FBW FBW/IBW pretreated first week second week
A 21.00 ± 2.64 24.28 ± 2.10 1.16 12.38 ± 3.39 12.73 ± 3.48 17.01 ± 8.20
B 21.58 ± 2.34 24.90 ± 1.91 1.15 9.28 ± 0.58 9.70 ± 3.67 8.61 ± 2.23
C 22.88 ± 2.90 20.03 ± 1.10 0.87 17.77 ± 2.51 14.84 ± 2.6 9.82 ± 2.56
D 23.35 ± 0.15 20.67 ± 2.65 0.89 7.26 ± 1.11 7.31 ± 0.21 7.01 ± 1.48
  1. IBW is the initial body weight; FBW is the final body weight; A is control group; B is Res treatment; C is Cis treatment; D is combined treatment